MedTrace Logo

Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction

NCT03933995 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2020-10-22

No results posted yet for this study

Summary

This is a 5year (+-30 days) long term follow up study to evaluate the safety of autologous bone marrow derived mesenchymal stem cell in erectile dysfunction subject who participated in and completed the Phase 1 trials (refer to ClinicalTrials.gov.Identifier: NCT02344849).

Conditions

Interventions

OTHER

no Intervention

no Intervention

Sponsors & Collaborators

  • Pharmicell Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chungsu Kim, Ph.D · Asan Medical Center

Eligibility

Min Age
20 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-11
Primary Completion
2022-02-28
Completion
2022-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03933995 on ClinicalTrials.gov